Triple negative breast cancer (TNBC) is a subtype of breast tumor lacking hormone
receptors expression and HER2 gene amplification and represents 24% of newly diagnosed …

Triple-negative breast cancer (TNBC) is defined as a type of breast cancer with lack of
expression of estrogen receptor (ER), progesterone receptor (PR) and HER2 protein. The …

Aims and background Triple-negative breast cancer, defined by a lack of expression of
estrogen, progesterone and HER-2 receptors, accounts for 15% of all types of breast cancer …

Triple-negative breast cancer (TNBC) is a heterogeneous disease diagnosed by
immunohistochemistry and is characterised by tumours that do not express estrogen …

Objectives: Triple-negative breast cancer is regarded as an aggressive disease that affects a
young patient population and for which effective targeted therapy is not yet available …

Triple negative breast cancer (TNBC) is a complex and malignant breast cancer subtype that
lacks expression of the estrogen receptor (ER), progesterone receptor (PR) and human …

Triple-negative breast cancers (TNBCs) are a diverse and heterogeneous group of tumors
that by definition lack estrogen and progesterone receptors and amplification of the HER2 …

Breast cancer is a heterogeneous disease, encompassing a large number of entities
showing different morphological features and having clinical behaviors. It has became …

Triple-negative breast cancers (TNBCs) are defined as tumors that are negative for
estrogen, progesterone and HER-2 receptor. At a percentage of 10-20% TNBCs represent a …

Triple negative breast cancers are defined by the absence of oestrogen, progesterone and
HER2 expression. Most triple negative cancers display distinct clinical and pathological …